The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis.

Nancy L KeatingGabriel A BrooksMary Beth LandrumPang-Hsiang LiuRobert WolfLauren E RiedelNirav S KapadiaShalini JhatakiaAmanda TrippCarol SimonVan Doren HsuColleen M KummetAndrea Hassol

Published in: Journal of the National Cancer Institute (2022)

OCM did not impact adherence to oral cancer therapies for Medicare beneficiaries with CML, prostate cancer, or breast cancer overall but modestly improved adherence to high-cost TKIs and antiandrogens for Black beneficiaries, who had somewhat lower adherence than White beneficiaries at baseline. Patient navigation and financial counseling are potential mechanisms for improvement among Black beneficiaries.

Keyphrases

prostate cancer
palliative care
healthcare
case report
type diabetes
radical prostatectomy
metabolic syndrome
adipose tissue
skeletal muscle
pain management
young adults
smoking cessation
insulin resistance
hiv infected
men who have sex with men
hiv testing
antiretroviral therapy
data analysis
childhood cancer